Logo-bi
Editorial
Azam Safary ORCID, Mostafa Akbarzadeh Khiavi ORCID, Rahimeh Mousavi, Jaleh Barar ORCID, Mohammad A Rafi*
Bioimpacts. 2018;8(3): 153-157. doi: 10.15171/bi.2018.17
PMCID: PMC6128977     PMID: 30211074     Scopus ID: 85050655722    
Original Research
Azam Safary ORCID, Rezvan Moniri, Maryam Hamzeh-Mivehroud, Siavoush Dastmalchi*
Bioimpacts. 2019;9(1): 15-23. doi: 10.15171/bi.2019.03
PMCID: PMC6378094     PMID: 30788256     Scopus ID: 85060439417    
The current study introduces a new and efficient recombinant L-asparaginase (ASPase) enzyme from locally isolated halo-thermotolerant Bacillus. The activity assay of ASPase A1 and ASPase A3 showed that only ASPase A1 is an active and stable homologues enzyme with high substrate affinity toward L-asparagine.
Editorial
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071152476    
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.
Original Research
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
The current study introduces an efficient ROS-responsive enzyme-based nanobiosystem and its biological impact in colon cancer therapy. Based on physicochemical properties, AuNPs-PEG-RNase A effectively induced apoptosis in SW-480 colon cancer cells and resulted in a significant reduction in cancer cell viability.
Editorial
Marziyeh Fathi ORCID, Azam Safary ORCID, Jaleh Barar* ORCID
Bioimpacts. 2020;10(1): 1-4. doi: 10.15171/bi.2020.01
PMCID: PMC6977590     PMID: 31988850     Scopus ID: 85078980716    
Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.
Editorial
Azam Safary ORCID, Mostafa Akbarzadeh-Khiavi ORCID, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(4): 269-273. doi: 10.34172/bi.2023.27494
PMCID: PMC10460773     PMID: 37645029     Scopus ID: 85168085723    
Professor Yadollah Omidi has a Ph.D. degree in Pharmaceutical Sciences (2003, Cardiff University, UK). He is currently working as a full professorat Nova Southeastern University College of Pharmacy, Florida. He has consecutively been listedamong top 1% highly cited scientists worldwide by WoS-ESI.
Editorial
Mostafa Akbarzadeh-Khiavi ORCID, Azam Safary ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2024;14(1): 27696. doi: 10.34172/bi.2023.27696
PMCID: PMC10844586     PMID: 38327631    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge